Why is a government task force spending time on analyzing what the cost savings would be from a large-scale commercial system to reimport low-cost Rx drugs from Canada? Is there any surprise in the finding that the cost savings would be negligible?
Senator Byron Dorgan (D-N.D.) said, "I never had much confidence that this study was going to be objective. Millions of Americans obtain prescription medicines from Canada and other countries and do so safely. The federal government itself is buying flu vaccine from abroad right now. The only thing endangered ... is the incrredibly large profits of the drug companies."
Meantime, why must all reform proposals travel the twisted road of Canadian reimportations? Why doesn't the federal government take DIRECT action to negotiate with drug companies?